Showing 1 - 20 results of 38 for search 'PHARMACOECONOMICS', query time: 0.33s Refine Results
  1. 1
    Comparative pharmacoeconomical analysis of modern antidepressants in monotherapy
    by A. E. Cheberda, D. Yu. Belousov, S. K. Zyryanov
    Published 2018-05-01
    “... disorders with several other important antidepressants using pharmacoeconomic methods within context...”
    Get full text
    Article
  2. 2
    Pharmacoeconomic analysis of subdermal tocilizumab in patients with rheumatoid arthritis
    by S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  3. 3
    Pharmacoeconomic analysis of Xeomine® for treatment patients with focal dystonia
    by S. K. Zyryanov, D. Yu. Belousov, A. E. Cheberda
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  4. 4
    Pharmacoeconomic effectiveness of lenvatinib in patients with differentiated radioiodine-resistant thyroid cancer
    by S. K. Zyryanov, I. N. Dyakov
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  5. 5
    Clinical and pharmacoeconomic aspects of anti-TNF therapy change for medical reasons
    by U. S. Gushchina, S. K. Zyryanov, I. A. Orlikhina
    Published 2018-05-01
    “.... In this article, the available data on the impact of non-medical switching on the clinical and pharmacoeconomic...”
    Get full text
    Article
  6. 6
    Pharmacoeconomic evaluation of the ceftolosan + tasobactam in the treatment of complicated nosocomial intraabdominal infections
    by I. N. Dyakov, S. K. Zyryanov, N. N. Khachatryan
    Published 2019-10-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  7. 7
    CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
    by I. I. Shteynberg, S. K. Zyryanov, Yu. B. Belousov
    Published 2015-03-01
    “... in Moscow’s hospitals. The aim of the study was to compare the clinical and pharmacoeconomical efficacy...”
    Get full text
    Article
  8. 8
    Pharmacoeconomic assessment of urinary tract infections in infants born to mather with pathological pregnancy
    by O. A. Shulakova, K. G. Gurevitch, S. K. Zyryanov
    Published 2016-04-01
    Subjects: “...pharmacoeconomic score...”
    Get full text
    Article
  9. 9
    Pharmacoeconomic analysis of flexible-dose administration regimen of Xeomine® in patients with focal dystonia
    by A. E. Cheberda, D. Yu. Belousov, S. K. Zyryanov
    Published 2018-06-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  10. 10
    Pharmacoeconomic comparison of insulin glargine and insulin detemir in diabetes mellitus type 2
    by I. N. Dyakov, S. K. Zyryanov
    Published 2020-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  11. 11
    Pharmacoeconomics of dapagliflozin in patients with type 2 diabetes mellitus with inadequate glycemic control
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  12. 12
    PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS
    by S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  13. 13
    Comparative pharmacoeconomic analysis of medication for patients after acute decompensated heart failure
    by S. K. Zyryanov, E. A. Ushkalova
    Published 2020-02-01
    “...Aim. Pharmacoeconomic comparison of medication management strategies (valsartan+ sacubitril...”
    Get full text
    Article
  14. 14
    Review the results of pharmacoeconomic trials of antiplatelet drugs in the treatment of patients with acute coronary syndrome
    by S. K. Zyryanov, E. V. Dumchenko
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  15. 15
    Comparative pharmacoeconomic analysis of ceffaroline fosamil in the treatment of complicated skin and soft tissues infections
    by S. K. Zyryanov, D. Yu. Belousov, E. V. Afanasyeva
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  16. 16
    Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation
    by S. K. Zyryanov, I. N. Diyakov, S. N. Avdeev
    Published 2020-02-01
    “...Objective – to conduct a pharmacoeconomic analysis of using omalizumab, mepolizumab and reslizumab...”
    Get full text
    Article
  17. 17
    CLINICAL AND ECONOMICAL ASPECTS OF NOVEL APPROACHES TO THE TREATMENT OF CHRONIC HEART FAILURE DECOMPENSATION
    by S. K. Zyryanov, G. P. Arutyunov
    Published 2015-03-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  18. 18
    Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price
    by D. A. Ivanov, I. N. Dyakov, S. K. Zyryanov
    Published 2021-07-01
    Get full text
    Article
  19. 19
    Pharmacoeconomics expediency of application of the combined preparation of Vezomni in comparison with a combination of Tamsulosin and Solifenacin in the form of monopreparations
    by S. K. Zyryanov, I. N. Dyakov
    Published 2018-06-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
  20. 20
    Pharmacoeconomic analysis of Actemra<sup>®</sup> in first-line treatment of rheumatoid arthritis in the modes of combination and monotherapy
    by S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
    Published 2018-05-01
    Subjects: “...pharmacoeconomics...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search